Follow
Allarity Therapeutics A/S
Nasdaq First North GM (Sweden)
Allarity Therapeutics AS is a late clinical-stage, precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers guided by its proprietary drug response predictor technology, the DRP platform. The product portfolio includes stenoparib (2X-121), a PARP inhibitor in Phase 2 for ovarian cancer; dovitinib, a pan-TKI in post-Phase 3 for renal cell carcinoma; IXEMPRA (ixabepilone), a microtubulin inhibitor for the treatment of breast can Allarity Therapeutics AS is a late clinical-stage, precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers guided by its proprietary drug response predictor technology, the DRP platform. The product portfolio includes stenoparib (2X-121), a PARP inhibitor in Phase 2 for ovarian cancer; dovitinib, a pan-TKI in post-Phase 3 for renal cell carcinoma; IXEMPRA (ixabepilone), a microtubulin inhibitor for the treatment of breast cancer; LiPlaCis, a liposomal formulation of cisplatin in Phase 2 trials for breast and prostate cancer; 2X-111, a liposomal formulation of doxorubicin under manufacturing for Phase 2 in breast cancer; and irofulven, a DNA damaging agent in Phase 2 for prostate cancer.

Read more

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Exercise
Price
6.00 SEK
Exercise period(s)
01 Apr - 15 Apr 2020
01 Sep - 15 Sep 2020
01 Feb - 15 Feb 2021
01 May - 15 May 2021
01 Sep - 15 Sep 2021
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
ALLR
DK0060732477
Nasdaq First North GM
Sweden (SE)
Details of share in Allarity Therapeutics A/S with ticker ALLR
Status
Active
Order book id
Amount of instruments
191 754 351
Par value
Currency
SEK
Type
Price
Pre-money valuation
Time
Files
Listing
08 Oct 2013
Direct listing of Allarity Therapeutics A/S on Nasdaq First North GM
Type
Price
Pre-money valuation
Time
Files
Rights issue
180.00 DKK
187.32M DKK
22 Sep - 03 Oct 2014
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Private placement
135.00 DKK
148.47M DKK
19 Feb 2016
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Rights issue
14.80 SEK
349.47M SEK
14 Jun - 29 Jun 2017
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Rights issue
4.00 SEK
201.25M SEK
17 Apr - 10 May 2019
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Exercise
7.50 SEK
01 Jun - 07 Jun 2019
01 Sep - 06 Sep 2019
01 Dec - 06 Dec 2019
Option exercise terms for OV TO 1
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.00 SEK
141.41M SEK
31 Oct - 21 Nov 2019
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Debt conversion
2.20 SEK
266.31M SEK
10 Jan 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Debt conversion
1.77 SEK
231.28M SEK
07 May 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Convertible issue
1.33 SEK
212.11M SEK
09 Jun 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Convertible issue
1.33 SEK
213.11M SEK
10 Jun 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.4968 SEK
243.22M SEK
18 Jun 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Convertible issue
1.27 SEK
212.94M SEK
30 Jun 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Set-off issue
1.52 SEK
257.25M SEK
13 Jul 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Convertible issue
1.33 SEK
241.56M SEK
14 Jul 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Convertible issue
1.32 SEK
242.72M SEK
14 Aug 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.7438 SEK
337.21M SEK
06 Oct 2020
Share issue in Allarity Therapeutics A/S
Type
Ticker
ISIN
Market
OPTION
ALLR TO 2
DK0061153657
Nasdaq First North GM
Sweden (SE)
Details of option in Allarity Therapeutics A/S with ticker ALLR TO 2
Status
Active
Order book id
Amount of instruments
50 341 080
Currency
SEK
Segment
First North
Trading period
04 Feb 2020 - 13 Sep 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.00 SEK
01 Apr - 15 Apr 2020
01 Sep - 15 Sep 2020
01 Feb - 15 Feb 2021
01 May - 15 May 2021
01 Sep - 15 Sep 2021
Option exercise terms for ALLR TO 2
Type
Ticker
ISIN
Market
SHARE
MPI
DK0060514487
Nasdaq First North GM
Denmark (DK)
Details of share in Allarity Therapeutics A/S with ticker MPI
Status
Archived
Order book id
Amount of instruments
Par value
Currency
DKK
Type
Price
Pre-money valuation
Time
Files
Listing
08 Oct 2013
Direct listing of Allarity Therapeutics A/S on Nasdaq First North GM
Type
Price
Pre-money valuation
Time
Files
Rights issue
180.00 DKK
187.32M DKK
22 Sep - 03 Oct 2014
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Private placement
135.00 DKK
148.47M DKK
19 Feb 2016
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Rights issue
14.80 SEK
349.47M SEK
14 Jun - 29 Jun 2017
Share issue in Allarity Therapeutics A/S
Type
Ticker
ISIN
Market
SHARE
OV
DK0060732477
Nasdaq First North GM
Sweden (SE)
Details of share in Allarity Therapeutics A/S with ticker OV
Status
Archived
Order book id
Amount of instruments
191 754 351
Par value
0.0500
Currency
SEK
Segment
First North
Type
Price
Pre-money valuation
Time
Files
Rights issue
4.00 SEK
201.25M SEK
17 Apr - 10 May 2019
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.00 SEK
141.41M SEK
31 Oct - 21 Nov 2019
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Debt conversion
2.20 SEK
266.31M SEK
10 Jan 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Debt conversion
1.77 SEK
231.28M SEK
07 May 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Convertible issue
1.33 SEK
212.11M SEK
09 Jun 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Convertible issue
1.33 SEK
213.11M SEK
10 Jun 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.4968 SEK
243.22M SEK
18 Jun 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Convertible issue
1.27 SEK
212.94M SEK
30 Jun 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Set-off issue
1.52 SEK
257.25M SEK
13 Jul 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Convertible issue
1.33 SEK
241.56M SEK
14 Jul 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Convertible issue
1.32 SEK
242.72M SEK
14 Aug 2020
Share issue in Allarity Therapeutics A/S
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.7438 SEK
337.21M SEK
06 Oct 2020
Share issue in Allarity Therapeutics A/S
Type
Ticker
ISIN
Market
SHARE
ALLR
DK0060732477
Nasdaq First North GM
Sweden (SE)
Details of share in Allarity Therapeutics A/S with ticker ALLR
Status
Active
Order book id
Amount of instruments
191 754 351
Par value
Currency
SEK
Type
Ticker
ISIN
Market
OPTION
OV TO 1
DK0061139581
Nasdaq First North GM
Sweden (SE)
Details of option in Allarity Therapeutics A/S with ticker OV TO 1
Status
Archived
Order book id
176918
Amount of instruments
20 166 221
Currency
SEK
Trading period
24 Jul 2019 - 22 May 2020
Terms
One (1) investor warrant entitles the holder to subscribe for one (1) new share in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
7.50 SEK
01 Jun - 07 Jun 2019
01 Sep - 06 Sep 2019
01 Dec - 06 Dec 2019
Option exercise terms for OV TO 1
Type
Ticker
ISIN
Market
OPTION
ALLR TO 2
DK0061153657
Nasdaq First North GM
Sweden (SE)
Details of option in Allarity Therapeutics A/S with ticker ALLR TO 2
Status
Active
Order book id
Amount of instruments
50 341 080
Currency
SEK
Segment
First North
Trading period
04 Feb 2020 - 13 Sep 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.00 SEK
01 Apr - 15 Apr 2020
01 Sep - 15 Sep 2020
01 Feb - 15 Feb 2021
01 May - 15 May 2021
01 Sep - 15 Sep 2021
Option exercise terms for ALLR TO 2
People
Steve Carchedi
CEO
Duncan Moore
Chairman of the board
Gail Maderis
Board member
Søren Gade
Board member
Duncan Moore
Board member
Company Details
Sector
HEALTH CARE

Address
Venlighedsvej 1
Zip code
2970
City/district
Hørsholm
Country
Denmark (DK)
Registration number
28106351
LEI code
213800FKAPK1MPJ18Q79
First trade date
22 Jul 2015
Company former names
Oncology Venture A/S
12 Oct 2020
Medical Prognosis Institute A/S
03 Sep 2018
Registration date
09 Sep 2004
Short name
Allarity

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date